Vortioxetine eases depression in older adults, while cognitive gains stay mixed—showing selective boosts in attention and processing speed, not consistent global improvement.
|Slideshows|June 5, 2018
Geriatric Psychiatry Research Update: June 2018
Author(s)Mark L. Fuerst
Three new studies examine research on biomarkers to predict lifetime risk of Alzheimer disease; diet and brain tissue volume; and cognitive impairment in active older adults.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
When Antidepressants Stop Working: Understanding Tachyphylaxis in Clinical Practice
2
Evidence-Based Ethical Principles for Long-Acting Injectable Antipsychotic Use
3
What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?
4
Sleep Disruption and Alzheimer Disease: A Bidirectional, Treatable Relationship
5